Cargando…
Molecular mechanisms involved in the IL-6-mediated upregulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression in the chorionic villi and decidua of women in early pregnancy
BACKGROUND: IL-6 induces the upregulation of indoleamine 2,3-dioxygenase (IDO1) at the maternal-foetal interface, but the regulation mechanisms of IDO1 by IL-6 at this interface have not been fully understood. METHODS: Western blotting, qRT–PCR and/or immunohistochemistry were employed to measure th...
Autores principales: | Wang, Rui, Zhao, Shuyun, Chen, Xiaojuan, Xiao, Ziwen, Wen, Xinghui, Zhong, Xingming, Li, Shixiang, Cheng, Hui, Huang, Guanyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805015/ https://www.ncbi.nlm.nih.gov/pubmed/36587196 http://dx.doi.org/10.1186/s12884-022-05307-5 |
Ejemplares similares
-
Relationship of SOCS3 and TGF-β with IDO expression in early pregnancy chorionic villi and decidua
por: Liu, Wei, et al.
Publicado: (2017) -
Indoleamine 2,3-Dioxygenase (IDO) Downregulates the Cell Surface Expression of the CD4 Molecule
por: Huang, Guanyou, et al.
Publicado: (2012) -
The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
por: Opitz, Christiane A., et al.
Publicado: (2011) -
Indoleamine 2,3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19
por: Guo, Lihui, et al.
Publicado: (2022) -
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
por: Tang, Kai, et al.
Publicado: (2021)